Detailed information for compound 1794583

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 421.399 | Formula: C23H19NO7
  • H donors: 0 H acceptors: 5 LogP: 2.32 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CC(=O)Oc1cc(cc2c1C(=O)c1c(C2=O)cccc1OC(=O)C)C(=O)N1CCCC1
  • InChi: 1S/C23H19NO7/c1-12(25)30-17-7-5-6-15-19(17)22(28)20-16(21(15)27)10-14(11-18(20)31-13(2)26)23(29)24-8-3-4-9-24/h5-7,10-11H,3-4,8-9H2,1-2H3
  • InChiKey: VIIQFLNWFOQSFD-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis sn1 specific diacylglycerol lipase beta 0.0769 1 1
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0754 0.9777 0.9777
Brugia malayi amidase 0.0754 0.9777 0.9777
Trypanosoma brucei lipase domain protein, putative 0.0769 1 1
Trypanosoma cruzi hypothetical protein, conserved 0.0769 1 1
Chlamydia trachomatis glutamyl-tRNA(Gln) amidotransferase subunit A 0.0091 0 0.5
Treponema pallidum aspartyl/glutamyl-tRNA amidotransferase subunit A 0.0091 0 0.5
Plasmodium falciparum glutamyl-tRNA(Gln) amidotransferase subunit A 0.0091 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0769 1 1
Loa Loa (eye worm) hypothetical protein 0.0754 0.9777 0.9777
Leishmania major hypothetical protein, conserved 0.0769 1 1
Wolbachia endosymbiont of Brugia malayi aspartyl/glutamyl-tRNA amidotransferase subunit A 0.0091 0 0.5
Trypanosoma brucei lipase domain protein, putative 0.0769 1 1
Echinococcus granulosus fatty acid amide hydrolase 1 0.0754 0.9777 0.9777
Schistosoma mansoni fatty-acid amide hydrolase 0.0754 0.9777 1
Loa Loa (eye worm) lipase 0.0769 1 1
Echinococcus granulosus sn1 specific diacylglycerol lipase beta 0.0769 1 1
Plasmodium vivax glutamyl-tRNA(Gln) amidotransferase subunit A, putative 0.0091 0 0.5
Echinococcus granulosus fatty acid amide hydrolase 1 0.0754 0.9777 0.9777
Trichomonas vaginalis lipase containing protein, putative 0.0769 1 0.5
Trichomonas vaginalis lipase containing protein, putative 0.0769 1 0.5
Mycobacterium leprae PROBABLE GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE (SUBUNIT A) GATA (Glu-ADT SUBUNIT A) 0.0091 0 0.5
Mycobacterium leprae PROBABLE AMIDASE AMIC (AMINOHYDROLASE) 0.0091 0 0.5
Mycobacterium ulcerans carboxylesterase, LipT 0.0155 0.0941 1
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0754 0.9777 0.9777
Schistosoma mansoni amidase 0.0754 0.9777 1
Onchocerca volvulus 0.0769 1 0.5
Mycobacterium tuberculosis Carboxylesterase LipT 0.0155 0.0941 1

Activities

Activity type Activity value Assay description Source Reference
Activity (functional) = 2.541 mmol/L Hypoglycemic activity in Homo sapiens (human) HepG2 cells assessed as glucose consumption at 100 mg/l after 24 hr by glucose enzymatic assay (Rvb = 1.972 +/-0.071 mmol/l) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.